LICOSER

Food supplement based on Serenoa repens, lycopene, zinc, vitamin E, useful to fill deficiencies in case of increased needs or reduced intake with diet. It can be used as an adjuvant in maintaining the physiological properties of the prostate gland.
Serenoa Repens (synonym for Sabal Serrulata)
Plant widespread in the United States, South Europe and North Africa. The most important chemical constituents are different sterols, free fatty acids, carotenoids, essential oils and polysaccharides.
Useful for the proper functioning of the urinary tract and prostate.
Licopene
Natural pigment belonging to the class of carotenoids, is characterized by antioxidant properties similar to those of beta-carotene, but it is much more powerful, therefore much more effective in preventing the damage of free oxygen radicals. In nature Licopene is present in tomatoes and other vegetable substances; equipped with high antioxidant activity, is considered among the carotenoids the most powerful "scavanger" (spazzino) of the free radicals of oxygen.
Urtica Dioica
Perennial herbaceous plant, native to western Asia, spread in all temperate regions, Italy included. In modern phytotherapy the root plays a prominent role, in fact it is rich in phytosterols (α-sitosterol, daucosterol and its glucosides), with mechanism of action similar to those of the Serenoa but also contains lecitines (scopoletine) that inhibit the EEGF (Epidermal Grow Factor) a factor of cellular growth that reduces the symptomatology and also partially. Therefore the root extract of Urtica Dioica is of particular benefit to limit the growth of the prostate tissue induced by androgens and in particular by dihydrotestosterone.
Green tea
It is derived from the buds of the leaves and the young leaves of the plant known as "Camelia sinensis". The peculiarity of this plant is given by the high antioxidant potential.
It contains neither gluten nor sugar.

Ingredients

	for 1 tablet (1200 mg)
Serenoa repens (e.s. 30% total fatty acids)	320 mg
Licopene	8 mg
Zinc	11,25 mg
Vitamin E	15 mg

Mode of use
The treatment involves taking 1 - 2 tablets daily for a period of at least 6 - 12 months.
It can be taken indifferently at any time of the day and indifferently during meals or away from meals.

Warnings
Do not exceed the recommended daily dose. Keep out of reach of children under 3 years of age. Supplements should not be understood as substitutes for a varied diet. For pregnant or breastfeeding women and children it is recommended to feel the medical advice.

Format
Pack of 30 tablets.

Cod. 1010007.

Bibliography
-Carilla E,Briley M,Fauran F,Sultan C,Duvilliers C. Binding of Permixon,a new treatment for prostatic benign hyperplasia,to the cytosolic androgen receptor in the prostate rat.J Steroid Biochem 1984;20:521-3.
-Champault G,Patel JC,Bonnard QAM. A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia. Br J Clin Pharmacol 1984;18:461-2.
-De Bruyne F. et al. Evaluation of the clinical benefit Serenoa Repens and Tamsulosin in severe BPH patients-Personal study subset analysis.Eur.Urol. 2004 Jun;45(6):773-9;Discussion 779-80,2004.
-Boyle P,Robertson C,lowe F,Roehrborn C. Meta-analysis of clinical trials of Permixon in the treatmentof symptomatic benign prostatic hyperplasia.Urology 2000;55:533-9.
-Bent S. et al. Saw Palmetto for benign prostatic hyperplasya. N.Engl.J. Med. 354(6):557- 66,2006.
-Wilt T,Ishani A,Stark G,Mac donald R,Mulrow C,Lau J.Serenoa repens for benign prostatic hyperplasia.Cochrane Database Syst Rev 2000;2:CD001423.
-Fong YK, Milani S, Djavan B, Role of phytotherapy in men with lower urinary tract symptoms. Curr opin urol.2005; 15(1); 45-48.
-Wilt T, Ishani A, Mac Donald R, Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev,2002; 3; CDCD001423.
-Strauch G, Perles P, Vergult G, et al. Comparison of finasteride and Serenoa repens in the inhibition of 5-alpha reductase in healthy volunteers. Eur.Urology 1994; 26:3, 247-252.
-Debruyne F, Boyle P, Calais da Silva F, Gillenwater JG, Hamdy FC, Perrin P, Teillac P, Vela- Navarrete R, Raynaud JP, Schulman C, Eevation of the clinical benefit of permixon and tamsulosin in severe BPH patiens- PERMAL study subset analysis. Prog Urol, 2004 Jun;14(3):326-331.
-Avins A.L. et al. A detailed safety sistment of a Saw Palmetto extract.Complement ther med. 16(3):147-154,2008.
-Levy J.,Bosin E. Et al.,Lycopene is a more potent inhibitor of human cancer cell proliferation than eitherv a-carotene or b- carotene.Nutr. Cancer, 1995;24: 257-266.
-Sökeland J. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia:analysis of prostate volume and therapeutic outcome. BJU int 200; 86(4):439-442.
-Schneider T, Rubben H, Stinging nettle root extract in long term treatment of benign prostatic syndrome (BPS). Results of a randomized, duble-blind,placebo controlled multicenter study after 12 months. Urologe A, 2004; 43(3): 302-306.
-Lichius JJ, The inhibiting effects of components of stinging nettle roots on experimentally induced prostatic hyperplasia in myce. Planta Med,1999;65, 7: 666-668.
-Bombardelli E, Morazzoni P, Urtica Dioica L. Fitoterapia 1997; 68,5, 387-402.
-Chem Pharm, Bulletin 38-1990.
-Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane AS, Japan Public Health Center- Based Prospective Study Group. Dairy product, satured fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiol Biomarkers Prev, 2008 Apr; 17 (4): 930-937.
-Betuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A, Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. cancer Res,2006 Jan 15;66(2): 1234-1240.
-Etminan M, Takkouche B, Caamano-Isorna F The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev, 2004 Mar; 13 (3): 340-345.
-Michael B. Sporn and Karen T. Liby Is Lycopene an effective Agent for preventing prostate cancer? Cancer Prevention Research 14-03-2013.